Andrea Oliva

Head of Pharmacovigilance at Mylan

Graduated at Milan University in Pharmaceutical Biotechnology and bachelor degree in Biology Applied to Biomedical Research, started the work experience as a researcher in the field of infectious diseases. From 2009 he starts in the technical / scientific management team as QPPV deputy and responsible for Medical Information at Teofarma.

After a brief period in regulatory affairs at DOC Generici, he joint GB Pharma (consultant company and CRO) assuming the role of QPPV and Italian PV responsible for different companies. In the last period in GB Pharma, he is also coordinator of the Regulatory Affairs team. Until June 2017 he was responsible for pharmacovigilance in Boehringer Ingelheim Italy where he managed pharmacovigilance activities for Veterinary and Human products. Since July 2017 is Head of Pharmacovigilance for Mylan S.p.a. where he coordinates and manages pharmacovigilance activities including medical information.


Title: How Pharmacovigilance could support business

  • Current role of pharmacovigilance within the Company
  • New prospective for the pharmacovigilance department
  • Pharmacovigilance as business function: a case study